Neuromuscular dysfunction in patient-derived FUS(R244RR)-ALS iPSC model via axonal downregulation of neuromuscular junction proteins
Summary
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative condition characterized by the progressive degeneration of motor neurons (MNs), ultimately resulting in death due to respiratory failure. A common feature among ALS cases is the early loss of axons, pointing to defects in axonal transport and translation as initial disease indicators. ALS is associated with mutations in RNA-binding proteins, such as FUS (Fused in Sarcoma). Here, we established a FUSR244RR-ALS hiPSC-derived model that recapitulates the MN survival and muscle contractility defects characteristic of ALS patients. Analysis of the protein and mRNA expression profiles in axonal and somatodendritic compartments of ALS-afflicted and isogenic control MNs revealed a selective downregulation of proteins essential for the neuromuscular junction function in FUS-ALS axons. Furthermore, analysis of FUS CLIP and RIP data showed that FUS binds mRNAs encoding these proteins. This work shed light on the pathogenic mechanisms of ALS and emphasized the importance of axonal gene expression analysis in elucidating the mechanisms of neurodegenerative disorders. © The Author(s) 2025. Published by Oxford University Press on behalf of NAR Molecular Medicine.
| Authors | von Kügelgen N, Ludwik K, Mendonsa S, Römer C, Becher E, Breimann L, Strauch M, Mari T, Mongellaz S, Zuckerman B, Efendic F, Grexa N, Oliveras-Martinez A, Woehler A, Selbach M, La Bella V, Ulitsky I, Chekulaeva M |
|---|---|
| Journal | NAR molecular medicine |
| Publication Date | 2025 Apr;2(2):ugaf005 |
| PubMed | 41255704 |
| PubMed Central | PMC12429959 |
| DOI | 10.1093/narmme/ugaf005 |